Michael Spinner

Michael Spinner, PharmD, currently serves as a Medical Science Liaison for Virology (RSV) at The Medical Affairs Company (TMAC), focusing on RSV antivirals in high-risk populations since September 2023. Prior experience includes roles as a Medical Science Liaison in the Carolinas Territory for CareDx, Inc., and as a Kidney and Intestinal Transplant Clinical Pharmacist at Cleveland Clinic from August 2013 to November 2022. Additional experience encompasses a PGY2 Solid Organ Transplant Residency at Barnes-Jewish Hospital and a PGY1 Pharmacy Practice Residency at Johns Hopkins Medicine. Earlier career achievements include serving as a Senior Clinical Research Associate at Washington University School of Medicine and working with research teams in traumatic brain injury and Alzheimer's disease. Michael Spinner earned a Doctor of Pharmacy from the University of Health Sciences and Pharmacy in St. Louis, a Master of Arts in Biology (Immunology) from Washington University in St. Louis, and a Bachelor of Science in Chemistry and Biochemistry from Bradley University.